Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Cigna + Oscar small business health insurance available in California regions » 09:31
04/08/21
04/08
09:31
04/08/21
09:31
CI

Cigna

$240.26 /

+1.13 (+0.47%)

, OSCR

Oscar Health

$23.39 /

-1.06 (-4.34%)

Cigna (CI), and Oscar…

Cigna (CI), and Oscar Health (OSCR) announced that Cigna + Oscar small business health insurance will be available in the Bay Area, Central Coast, Greater Sacramento, Inland Empire, Los Angeles, Orange County, North Bay, and San Diego regions. California small businesses with between one and 100 employees will have access to services driven by the combination of Cigna's provider relationships and Oscar's approach to customer service and care navigation. Cigna and Oscar will share risk equally under a reinsurance agreement for solutions offered through this strategic partnership and plan to expand the partnership over time.

ShowHide Related Items >><<
CI Cigna
$240.26 /

+1.13 (+0.47%)

CI Cigna
$240.26 /

+1.13 (+0.47%)

03/17/21 Stephens
Amazon news latest sign of rising telehealth competition, says Stephens
03/09/21 BMO Capital
Cigna price target raised to $290 from $270 at BMO Capital
03/09/21 Truist
Cigna price target raised to $280 from $260 at Truist
03/09/21 Mizuho
Cigna price target raised to $264 from $229 at Mizuho
OSCR Oscar Health
$23.39 /

-1.06 (-4.34%)

03/29/21 Wells Fargo
Oscar Health initiated with an Overweight at Wells Fargo
03/29/21
Fly Intel: Top five analyst initiations
03/29/21 BofA
Oscar Health initiated with a Buy at BofA
03/29/21 Morgan Stanley
Oscar Health initiated with an Overweight at Morgan Stanley
CI Cigna
$240.26 /

+1.13 (+0.47%)

  • 03
    Mar
CI Cigna
$240.26 /

+1.13 (+0.47%)

OSCR Oscar Health
$23.39 /

-1.06 (-4.34%)

CI Cigna
$240.26 /

+1.13 (+0.47%)

OSCR Oscar Health
$23.39 /

-1.06 (-4.34%)

CI Cigna
$240.26 /

+1.13 (+0.47%)

Over a week ago
Initiation
Oscar Health initiated with an Overweight at Wells Fargo » 17:39
03/29/21
03/29
17:39
03/29/21
17:39
OSCR

Oscar Health

$25.22 /

-0.465 (-1.81%)

Wells Fargo analyst…

Wells Fargo analyst Stephen Baxter initiated coverage of Oscar Health with an Overweight rating and $37 price target. The company's proprietary technology platform, member engagement and satisfaction, and track record of membership growth are "highly impressive", the analyst tells investors in a research note. Oscar is also in the very early stages of an opportunity to monetize its technology and member experience and generate unregulated fee income from other health plans that lack the scale or technological sophistication to build and implement similar solutions, Baxter adds.

ShowHide Related Items >><<
OSCR Oscar Health
$25.22 /

-0.465 (-1.81%)

03/29/21
Fly Intel: Top five analyst initiations
03/29/21 BofA
Oscar Health initiated with a Buy at BofA
03/29/21 Morgan Stanley
Oscar Health initiated with an Overweight at Morgan Stanley
03/29/21 Cowen
Oscar Health initiated with a Market Perform at Cowen
  • 03
    Mar
OSCR Oscar Health
$25.22 /

-0.465 (-1.81%)

OSCR Oscar Health
$25.22 /

-0.465 (-1.81%)

Initiation
Fly Intel: Top five analyst initiations » 09:54
03/29/21
03/29
09:54
03/29/21
09:54
INNV

InnovAge

$24.80 /

+0.64 (+2.65%)

, OSCR

Oscar Health

$25.98 /

+0.295 (+1.15%)

, CTMX

CytomX Therapeutics

$7.89 /

+0.27 (+3.54%)

, FRO

Frontline

$7.55 /

-0.54 (-6.67%)

, CREE

Cree

$106.16 /

-1.38 (-1.28%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. InnovAge (INNV) initiated with a Buy at Goldman Sachs and Citi, initiated with an Overweight at Piper Sandler, initiated with an Equal Weight at Barclays and initiated with an Outperform at William Blair. 2. Oscar Health (OSCR) initiated with a Buy at Goldman Sachs, initiated with a Market Perform at Cowen, initiated with an Overweight at Morgan Stanley and initiated with a Buy at BofA. 3. CytomX Therapeutics (CTMX) initiated with an Overweight at JPMorgan. 4. Frontline (FRO) initiated with a Neutral at H.C. Wainwright. 5. Cree (CREE) initiated with a Buy at New Street. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
FRO Frontline
$7.55 /

-0.54 (-6.67%)

CTMX CytomX Therapeutics
$7.89 /

+0.27 (+3.54%)

CREE Cree
$106.16 /

-1.38 (-1.28%)

INNV InnovAge
$24.80 /

+0.64 (+2.65%)

03/29/21 William Blair
InnovAge initiated with an Outperform at William Blair
03/29/21 Barclays
InnovAge initiated with an Equal Weight at Barclays
03/29/21 Citi
InnovAge initiated with a Buy at Citi
03/29/21 Goldman Sachs
InnovAge initiated with a Buy at Goldman Sachs
OSCR Oscar Health
$25.98 /

+0.295 (+1.15%)

03/29/21 BofA
Oscar Health initiated with a Buy at BofA
03/29/21 Morgan Stanley
Oscar Health initiated with an Overweight at Morgan Stanley
03/29/21 Cowen
Oscar Health initiated with a Market Perform at Cowen
03/29/21 Credit Suisse
Oscar Health initiated with an Outperform at Credit Suisse
CTMX CytomX Therapeutics
$7.89 /

+0.27 (+3.54%)

03/29/21 JPMorgan
CytomX Therapeutics initiated with an Overweight at JPMorgan
03/23/21 Jefferies
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
09/22/20 Guggenheim
Guggenheim taking more conservative view, downgrades CytomX to Neutral
09/22/20 Guggenheim
CytomX Therapeutics downgraded to Neutral from Buy at Guggenheim
FRO Frontline
$7.55 /

-0.54 (-6.67%)

03/29/21 H.C. Wainwright
Frontline initiated with a Neutral at H.C. Wainwright
02/22/21
Fly Intel: Top five analyst downgrades
02/22/21 Jefferies
Frontline downgraded to Hold on valuation after earnings miss at Jefferies
02/22/21 Jefferies
Frontline downgraded to Hold from Buy at Jefferies
CREE Cree
$106.16 /

-1.38 (-1.28%)

03/29/21 New Street
New Street starts 'silicon carbide pure play' Cree with Buy, $120 target
03/29/21 New Street
Cree initiated with a Buy at New Street
03/01/21 BofA
Cree initiated with a Buy at BofA
02/22/21 Cowen
Cowen upgrades Cree on underappreciated device platform
FRO Frontline
$7.55 /

-0.54 (-6.67%)

CTMX CytomX Therapeutics
$7.89 /

+0.27 (+3.54%)

CREE Cree
$106.16 /

-1.38 (-1.28%)

  • 04
    Mar
  • 03
    Mar
  • 21
    Jan
OSCR Oscar Health
$25.98 /

+0.295 (+1.15%)

INNV InnovAge
$24.80 /

+0.64 (+2.65%)

CTMX CytomX Therapeutics
$7.89 /

+0.27 (+3.54%)

CREE Cree
$106.16 /

-1.38 (-1.28%)

OSCR Oscar Health
$25.98 /

+0.295 (+1.15%)

FRO Frontline
$7.55 /

-0.54 (-6.67%)

CREE Cree
$106.16 /

-1.38 (-1.28%)

Initiation
Oscar Health initiated with a Buy at BofA » 08:57
03/29/21
03/29
08:57
03/29/21
08:57
OSCR

Oscar Health

$25.69 /

-1.435 (-5.29%)

BofA analyst Kevin…

BofA analyst Kevin Fischbeck initiated coverage of Oscar Health with a Buy rating and $39 price target. Oscar Health has good visibility into growing revenues 30%-40%+ per year organically for the next several years, and achieve Insurance segment profitability by 2023, Fischbeck tells investors in a research note. The analyst adds that there is plenty of white space left for geographic expansion to continue and that Oscar Health is also poised to benefit from legislative tailwinds.

ShowHide Related Items >><<
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

03/29/21 Morgan Stanley
Oscar Health initiated with an Overweight at Morgan Stanley
03/29/21 Cowen
Oscar Health initiated with a Market Perform at Cowen
03/29/21 Credit Suisse
Oscar Health initiated with an Outperform at Credit Suisse
03/29/21 Goldman Sachs
Oscar Health initiated with a Buy at Goldman Sachs
  • 03
    Mar
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

Initiation
Oscar Health initiated with an Overweight at Morgan Stanley » 08:47
03/29/21
03/29
08:47
03/29/21
08:47
OSCR

Oscar Health

$25.69 /

-1.435 (-5.29%)

Morgan Stanley analyst…

Morgan Stanley analyst Ricky Goldwasser initiated coverage of Oscar Health with an Overweight rating and $44 price target. Oscar's "consumer-centric" software platform has supported growth to $1.6B in healthcare insurance revenues in 2020 and while investors may be hesitant to give the company credit for their technology opportunity and skeptical that Oscar can profitably grow share in the healthcare insurance marketplace, Goldwasser said she is confident that the company can market its software and service offering to regional health plans and achieve high single-digit enterprise margins. Noting that the shares are down about 34% since the March 3 IPO, Goldwasser thinks new deal announcements should increase investor confidence and drive re-rating of the stock's multiple.

ShowHide Related Items >><<
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

03/29/21 Cowen
Oscar Health initiated with a Market Perform at Cowen
03/29/21 Credit Suisse
Oscar Health initiated with an Outperform at Credit Suisse
03/29/21 Goldman Sachs
Oscar Health initiated with a Buy at Goldman Sachs
  • 03
    Mar
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

Initiation
Oscar Health initiated with a Market Perform at Cowen » 06:04
03/29/21
03/29
06:04
03/29/21
06:04
OSCR

Oscar Health

$25.69 /

-1.435 (-5.29%)

Cowen analyst Charles…

Cowen analyst Charles Ryhee initiated coverage of Oscar Health with a Market Perform rating and $29 price target. The analyst likes its exposure to higher margin end markets, strong growth profile, and growth potential in the platform business but he is cautious on the individual exchange market given rising competition.

ShowHide Related Items >><<
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

03/29/21 Credit Suisse
Oscar Health initiated with an Outperform at Credit Suisse
03/29/21 Goldman Sachs
Oscar Health initiated with a Buy at Goldman Sachs
  • 03
    Mar
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

Initiation
Oscar Health initiated with an Outperform at Credit Suisse » 05:58
03/29/21
03/29
05:58
03/29/21
05:58
OSCR

Oscar Health

$25.69 /

-1.435 (-5.29%)

Credit Suisse analyst…

Credit Suisse analyst Jailendra Singh initiated coverage of Oscar Health with an Outperform rating and $34 price target. The analyst says the main growth drivers for Oscar over the next 10 years are acquiring members in existing markets, launching new markets and states, introducing new products, creating new partnerships and potential acquisitions.

ShowHide Related Items >><<
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

03/29/21 Goldman Sachs
Oscar Health initiated with a Buy at Goldman Sachs
  • 03
    Mar
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

Initiation
Oscar Health initiated with a Buy at Goldman Sachs » 05:01
03/29/21
03/29
05:01
03/29/21
05:01
OSCR

Oscar Health

$25.69 /

-1.435 (-5.29%)

Goldman Sachs analyst…

Goldman Sachs analyst Robert Jones initiated coverage of Oscar Health with a Buy rating and $44 price target. Oscar represents an opportunity to buy into a "differentiated offering that is levered to attractive secular themes" in healthcare, Jones tells investors in a research note. The analyst says the company is capable of growing sales at a 40%-plus organic rate. The stock's risk/reward is attractive given the "supportive backdrop" to its core end market and tech platform optionality, says the analyst.

ShowHide Related Items >><<
  • 03
    Mar
OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

OSCR Oscar Health
$25.69 /

-1.435 (-5.29%)

Over a month ago
Options
Four new option listings and three option delistings on March 9th » 08:30
03/09/21
03/09
08:30
03/09/21
08:30
OSCR

Oscar Health

$31.89 /

+0.88 (+2.84%)

, VIEW

View Inc.

$0.00 /

+ (+0.00%)

, VWTR

Vidler Water Resources

$9.95 /

+0.51 (+5.40%)

, CFII

CF Finance Acquisition Corp. II

$9.17 /

+0.8 (+9.56%)

, OXFD

Oxford Immunotec

$21.98 /

+ (+0.00%)

, PICO

Vidler Water Resources - use VWTR

$0.00 /

+ (+0.00%)

New option listings for…

New option listings for March 9th include Vaneck Vectors Social Sentiment Etf (BUZZ), Oscar Health Inc (Class A Stock) (OSCR), View Inc (Class A Stock) (VIEW), and Vidler Water Resources Inc (VWTR). Option delistings effective March 9th include CF Finance Acquisition Corporation II (Class A Stock) (CFII), Oxford Immunotec Global PLC (OXFD), and PICO Holdings Inc (PICO).

ShowHide Related Items >><<
PICO Vidler Water Resources - use VWTR
$0.00 /

+ (+0.00%)

OXFD Oxford Immunotec
$21.98 /

+ (+0.00%)

CFII CF Finance Acquisition Corp. II
$9.17 /

+0.8 (+9.56%)

OSCR Oscar Health
$31.89 /

+0.88 (+2.84%)

VIEW View Inc.
$0.00 /

+ (+0.00%)

VWTR Vidler Water Resources
$9.95 /

+0.51 (+5.40%)

CFII CF Finance Acquisition Corp. II
$9.17 /

+0.8 (+9.56%)

OXFD Oxford Immunotec
$21.98 /

+ (+0.00%)

01/07/21 JPMorgan
Oxford Immunotec downgraded to Neutral from Overweight at JPMorgan
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
12/18/20 Piper Sandler
Oxford Immunotec price target raised to $24 from $18 at Piper Sandler
08/13/20
Fly Intel: Top five analyst initiations
PICO Vidler Water Resources - use VWTR
$0.00 /

+ (+0.00%)

OXFD Oxford Immunotec
$21.98 /

+ (+0.00%)

  • 03
    Mar
OXFD Oxford Immunotec
$21.98 /

+ (+0.00%)

OSCR Oscar Health
$31.89 /

+0.88 (+2.84%)

On The Fly
Opening Day: InnovAge rises, Oscar Health slips on first trading day » 09:14
03/07/21
03/07
09:14
03/07/21
09:14
INNV

InnovAge

$25.16 /

+1 (+4.14%)

, OSCR

Oscar Health

$31.01 /

-1.02 (-3.19%)

, VPCC

VPC Impact Acquisition Holdings III

$0.00 /

+ (+0.00%)

, VPCB

VPC Impact Acquisition Holdings II

$0.00 /

+ (+0.00%)

, WPCA

Warburg Pincus Capital Corporation I-A

$0.00 /

+ (+0.00%)

, ATVC

Tribe Capital Growth Corp I

$0.00 /

+ (+0.00%)

, WPCB

Warburg Pincus Capital Corporation I-B

$0.00 /

+ (+0.00%)

, DMYQ

dMY Technology Group IV

$0.00 /

+ (+0.00%)

, TWNT

Tailwind Two Acquisition

$0.00 /

+ (+0.00%)

, FRSG

First Reserve Sustainable Growth

$0.00 /

+ (+0.00%)

, IPVI

InterPrivate IV InfraTech Partners

$0.00 /

+ (+0.00%)

, IPVF

InterPrivate III Financial Partners

$0.00 /

+ (+0.00%)

, IPVA

InterPrivate II Acquisition

$0.00 /

+ (+0.00%)

, PSAGU

Property Solutions Acquisition II

$10.00 /

+0.04 (+0.40%)

, KVSA

Khosla Ventures Acquisition

$10.69 /

+0.43 (+4.19%)

, AURC

Aurora Acquisition

$0.00 /

+ (+0.00%)

, ATAQ

Altimar Acquisition Corp. III

$0.00 /

+ (+0.00%)

, TRCA

Twin Ridge Capital Acquisition

$0.00 /

+ (+0.00%)

, ISOS

Isos Acquisition

$0.00 /

+ (+0.00%)

, MACC

Mission Advancement

$0.00 /

+ (+0.00%)

, ROCR

Roth CH Acquisition III

$0.00 /

+ (+0.00%)

, DHBC

DHB Capital

$0.00 /

+ (+0.00%)

, GBRG

Goldenbridge Acquisition

$0.00 /

+ (+0.00%)

, TSPQ

TCW Special Purpose Acquisition

$0.00 /

+ (+0.00%)

, FTEV

FinTech Evolution Acquisition

$0.00 /

+ (+0.00%)

, SNII

Supernova Partners Acquisition II

$0.00 /

+ (+0.00%)

, OPHA

Orion Acquisition

$0.00 /

+ (+0.00%)

, NDAC

NightDragon Acquisition

$0.00 /

+ (+0.00%)

, ANZU

Anzu Special Acquisition Corp I

$0.00 /

+ (+0.00%)

, NSTD

Northern Star Investment Corp. IV

$0.00 /

+ (+0.00%)

, NSTC

Northern Star Investment Corp. III

$0.00 /

+ (+0.00%)

, LOKM

Live Oak Mobility Acquisition

$0.00 /

+ (+0.00%)

, AMPI

Advanced Merger Partners

$0.00 /

+ (+0.00%)

, COIN

Coinbase

$0.00 /

+ (+0.00%)

, RBLX

Roblox

$0.00 /

+ (+0.00%)

, VZIO

Vizio

$0.00 /

+ (+0.00%)

, GROY

Gold Royalty

$0.00 /

+ (+0.00%)

, ALHC

Alignment Healthcare

$0.00 /

+ (+0.00%)

, HOOD

Robinhood

$0.00 /

+ (+0.00%)

, PLTR

Palantir

$23.92 /

-0.83 (-3.35%)

, ASAN

Asana

$30.61 /

-0.04 (-0.13%)

, WORK

Slack Technologies

$40.44 /

+0.465 (+1.16%)

, SPOT

Spotify

$274.70 /

-10.14 (-3.56%)

, BABA

Alibaba

$233.65 /

+3.575 (+1.55%)

Elder-care company…

ShowHide Related Items >><<
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

INNV InnovAge
$25.16 /

+1 (+4.14%)

OSCR Oscar Health
$31.01 /

-1.02 (-3.19%)

VPCC VPC Impact Acquisition Holdings III
$0.00 /

+ (+0.00%)

VPCB VPC Impact Acquisition Holdings II
$0.00 /

+ (+0.00%)

WPCA Warburg Pincus Capital Corporation I-A
$0.00 /

+ (+0.00%)

ATVC Tribe Capital Growth Corp I
$0.00 /

+ (+0.00%)

WPCB Warburg Pincus Capital Corporation I-B
$0.00 /

+ (+0.00%)

DMYQ dMY Technology Group IV
$0.00 /

+ (+0.00%)

TWNT Tailwind Two Acquisition
$0.00 /

+ (+0.00%)

FRSG First Reserve Sustainable Growth
$0.00 /

+ (+0.00%)

IPVI InterPrivate IV InfraTech Partners
$0.00 /

+ (+0.00%)

IPVF InterPrivate III Financial Partners
$0.00 /

+ (+0.00%)

IPVA InterPrivate II Acquisition
$0.00 /

+ (+0.00%)

PSAGU Property Solutions Acquisition II
$10.00 /

+0.04 (+0.40%)

KVSA Khosla Ventures Acquisition
$10.69 /

+0.43 (+4.19%)

AURC Aurora Acquisition
$0.00 /

+ (+0.00%)

ATAQ Altimar Acquisition Corp. III
$0.00 /

+ (+0.00%)

TRCA Twin Ridge Capital Acquisition
$0.00 /

+ (+0.00%)

ISOS Isos Acquisition
$0.00 /

+ (+0.00%)

MACC Mission Advancement
$0.00 /

+ (+0.00%)

ROCR Roth CH Acquisition III
$0.00 /

+ (+0.00%)

DHBC DHB Capital
$0.00 /

+ (+0.00%)

GBRG Goldenbridge Acquisition
$0.00 /

+ (+0.00%)

TSPQ TCW Special Purpose Acquisition
$0.00 /

+ (+0.00%)

FTEV FinTech Evolution Acquisition
$0.00 /

+ (+0.00%)

SNII Supernova Partners Acquisition II
$0.00 /

+ (+0.00%)

OPHA Orion Acquisition
$0.00 /

+ (+0.00%)

NDAC NightDragon Acquisition
$0.00 /

+ (+0.00%)

ANZU Anzu Special Acquisition Corp I
$0.00 /

+ (+0.00%)

NSTD Northern Star Investment Corp. IV
$0.00 /

+ (+0.00%)

NSTC Northern Star Investment Corp. III
$0.00 /

+ (+0.00%)

LOKM Live Oak Mobility Acquisition
$0.00 /

+ (+0.00%)

AMPI Advanced Merger Partners
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 DA Davidson
Coinbase initiated with a Buy at DA Davidson
RBLX Roblox
$0.00 /

+ (+0.00%)

VZIO Vizio
$0.00 /

+ (+0.00%)

GROY Gold Royalty
$0.00 /

+ (+0.00%)

ALHC Alignment Healthcare
$0.00 /

+ (+0.00%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

02/17/21
Fly Intel: Top five analyst upgrades
02/17/21 RBC Capital
Palantir price target raised to $27 from $15 at RBC Capital
02/17/21 Jefferies
Palantir 'a highly unique story for long-term investors,' says Jefferies
02/17/21 Morgan Stanley
Palantir price target raised to $19 from $17 at Morgan Stanley
ASAN Asana
$30.61 /

-0.04 (-0.13%)

03/05/21
Fly Intel: Top five analyst initiations
03/05/21 Baird
Asana initiated with an Outperform, $40 price target at Baird
03/04/21 Baird
Asana initiated with an Outperform at Baird
01/15/21 Credit Suisse
Asana assumed with a Neutral at Credit Suisse
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

03/05/21 DA Davidson
Slack Technologies price target lowered to $40 from $46 at DA Davidson
12/09/20 Morgan Stanley
Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley
12/09/20 Canaccord
Salesforce valuation compelling especially on pullback, says Canaccord
12/09/20 Morgan Stanley
Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
SPOT Spotify
$274.70 /

-10.14 (-3.56%)

02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 JPMorgan
Spotify price target raised to $385 from $350 at JPMorgan
02/23/21 Atlantic Equities
Spotify downgraded to Neutral from Overweight at Atlantic Equities
02/10/21 Pivotal Research
Spotify price target raised to $340 from $260 at Pivotal Research
BABA Alibaba
$233.65 /

+3.575 (+1.55%)

02/23/21 Credit Suisse
Farfetch price target raised to $85 from $53 at Credit Suisse
02/03/21 Raymond James
Alibaba price target raised to $350 from $330 at Raymond James
02/03/21 Mizuho
Alibaba price target raised to $285 from $270 at Mizuho
02/03/21 Macquarie
Alibaba price target raised to $395 from $387 at Macquarie
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

  • 09
    Mar
  • 04
    Mar
  • 03
    Mar
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

VZIO Vizio
$0.00 /

+ (+0.00%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

OSCR Oscar Health
$31.01 /

-1.02 (-3.19%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.